Event Details

You can now watch the Post-Graduate Courses from the 2023 ASM On-Demand. 

CT screening for lung cancer – the tide is changing as many jurisdictions are now considering or implementing CT screening for at risk individuals.  This succinct PG course will discuss the key issues in this transition period until broader uptake of low dose CT screening, to enable attendees to better understand the nuances of the data and potential implementation issues for Australia and New Zealand. This is a half-day course. 

Evidence Review

Chair: Kwun Fong

• Overview of screening - Paul Dawkins

• Harms of Lung Cancer screening - Renee Manser

• What is the optimal enrolment strategy for CT screening invitation? - Emily Stone

• How best to select individuals for screening – Fraser Brims

• Optimal CT screening parameters – Fraser Brims

• How to manage screen detected nodules – Emily Stone

• CAD, AI and Radiomics, MEVIS CAD Live Demo - Henry Marshall

Implementation Science

Chairs: Kwun Fong, Henry Marshall

• Are incidental findings on CT screening of clinical importance? - Renee Manser

• Smoking cessation - Henry Marshall

• Implementation Issues Aus – Kwun Fong

• Implementation Issues NZ – Sue Crengle

Proudly sponsored by Roche.